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Background: The hepatitis B virus x gene (HBx) is a promiscuous
transactivator implicated in the development of hepatocellular
carcinoma (HCC). The present study was designed to investigate
the molecular events regulated by HBx. Methods: Genomic and
proteomic expression proﬁling was performed in Huh7 HCC cells
transfected with HBx mutants with a C-terminal deletion. The
gene and protein expression of wingless-type murine-mammary-
tumour virus (MMTV) integration site family, member 5A (Wnt-5a)
was validated by analyses of reverse transcription–polymerase
chain reaction (RT–PCR), real-time RT–PCR, western blot and
immunohistochemistry. Results: Differentially expressed genes
and proteins were found in the transfected Huh7 HCC cells; most
of them were involved in transcriptional regulation, although
others including oncogenes or tumor suppressor genes, and mol-
ecules involved in cell junctions, signal transduction pathways,
metabolism or the immune response were also observed. The ex-
pression of the Wnt-5a gene was elevated >10-fold in Huh7 cells
transfected with the HBx3#-30 amino acid deletion mutant. How-
ever, the expression was downregulated by the transfection with
the HBx3#-40 amino acid deletion mutant. The changes in Wnt-5a
expression were also observed in human HCC tissues, compared
with corresponding non-cancerous liver tissues. A negative corre-
lation was found between the expression of Wnt-5a and HBx
COOH mutations in HCC tissues. Conclusions: HBx mutants
may participate in the development and progression of HCC, at
least in part through the Wnt-5a pathway.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common cancers
and a leading cause of cancer death in many countries, mainly in Asia
and Africa. Epidemiological evidence indicates that chronic hepatitis
B virus (HBV) infection is one of the main causes of HCC (1,2). In
addition to chronic inﬂammation and cirrhosis in the liver, HBV is
suspected to have a direct role in liver carcinogenesis (1,2).
The hepatitis B X protein antigen participates in the pathogenesis
of HCC (3). For example, high levels of intrahepatic hepatitis B X
protein antigen directly correlate with the stage of liver lesions (4).
Hepatitis B X protein antigen also binds to and inactivates or down-
regulates tumor suppressors and senescence-related factors (3). The
protein inhibits cell proliferation by inducing late G1 arrest (5) and
induces apoptosis in both a p53-dependent and -independent manner
(6,7). Hepatitis B virus x gene (HBx) has been shown to induce HCC
in several transgenic mouse models (8–10) and to have weak onco-
genic potential in several immortalized murine cell lines in vitro (11–
14). HBx can inhibit cellular DNA repair capacity in a p53-indepen-
dent manner (15). HBx also increases the expression of p21cip-1/waf1/
mda6 and p27kip-1 in primary mouse hepatocytes, and overexpression
of p21 and p27 can inhibit Cdk2 and Cdk4 activity, leading to cell
cycle arrest in the G1 phase (16), and activates Wnt/b-catenin signal-
ing in hepatoma cells (17). The gene expression proﬁles observed by
complementary DNA (cDNA) microarray showed that HBx can lead
to aberrant expression of molecules involved in signal transduction,
transcriptional regulation, protein degradation, cell cycle control,
apoptosis, metastasis, immune response and metabolism in mouse
hepatocyte cells (18). So, the role of HBx gene in the hepatocarcino-
genesis is still not understood and controversial.
We have shown previously that HBx can speciﬁcally bind the p53
protein and stimulates the transactivational activity of p53 and HBV
replication (6). Lin et al. (19) reported that the HBx-binding sites are
located within the oligomerization and speciﬁc DNA-binding do-
mains of p53, and that the p53-binding site is conﬁned in a small
region (102–136 aa) of the HBx C-terminal. The pro-transactivation
and the p53-inhibitory functions of HBx are mutually exclusive, in-
dicating that HBx can inﬂuence the growth of hepatocytes through
various pathways.
Several different deletions in the HBx gene C-terminal region have
been found in HBV-infected HCC patients (20–22). Murine and hu-
man cell lines transfected with HBx mutant plasmids show increases
in colony formation, cell cycle progression and ras and myc trans-
forming capacity (5). These results suggest that the HBx mutants with
C-terminal deletions may be implicated in the development and pro-
cession of HCC and that the C-terminal is vital for the biological
functions of the HBx protein. In our previous studies, we constructed
10 HBx mutants, including four N-terminal, two middle and four
C-terminal mutants, and analyzed the biological activities of the hep-
atoma cells with those truncated mutants of the HBx gene. The results
showed that HBx3#-40 at C-terminal mutant promoted cellular pro-
liferation, focus formation, tumorigenicity, invasive growth and
metastasis by promoting the cell cycle progression from G0/G1 to
S phase; in contrast, HBx3#-30 at C-terminal mutant repressed cell
proliferation by arresting cells in G1 phase (22). These suggesting
different forms of HBx share with the different functions and it may
be explained why the role of the HBx gene is contradiction in the
hepatocarcinogenesis.
In the present study, we analyzed the genomic and proteomic ex-
pression of HCC cells transfected with HBx with C-terminus muta-
tions, in order to better deﬁne the effects of the HBx mutants in the
development and procession of HCC associated with HBV infection.
Materials and methods
Cell line and culture
The Huh7 cell line (characterized by p53 mutation with A:T / G:C at codon
220) was cultured in Dulbecco’s minimum essential medium (Invitrogen Life
Abbreviations: cDNA, complementary DNA; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; HBV, hepatitis B virus; HBx, hepatitis B virus x
gene; HCC, hepatocellular carcinoma; mRNA, messenger RNA; MMTV,
murine-mammary-tumour virus; PCR, polymerase chain reaction; RT–PCR,
reverse transcription–polymerase chain reaction; Wnt-5a, wingless-type
MMTV integration site family, member 5A.
 The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
The onlineversion ofthis article hasbeen publishedunderan openaccess model.Users are entitledto use, reproduce,disseminate, ordisplay the openaccess version
of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are
attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.orgTechnologies, Grand Island, NY) with 10% heat-inactivated fetal calf serum,
100 000 units/l penicillin and 100 mg/l streptomycin at 37C in a 5% CO2
incubator.
Plasmid constructs
In order to evaluate the biological activities of HBx and to determine its trans-
activational effects, a series of C-terminal truncation mutants were made, since
the HBx transactivational function has been mapped to residues within these
regions (23). To express HBx mutants in the mammalian cells, the DNA frag-
mentpreciselyencompassingthe full-length HBx orHBx mutants withdeletions
of30or40aminoacidsattheC-terminusbeforetheﬁrststopcodonwerecloned
into the pcDNA3.0 vector (Invitrogen Life Technologies) using HindIII/XhoI
and KpnI/EcoRI sites. The mutants used in this study were generated by a poly-
merase chain reaction (PCR) cloning method using a PTKHH2 plasmid (a head-
to-tail dimer of wild-type HBV, adw subtype) as the template. The sequences of
primers for the full length and two HBx mutants are shown in supplementary
material 1 (available at Carcinogenesis Online). The PCR products were cloned
into a pcDNA3.0 expressionvector. Positive clones were sequenced to conﬁrm
their identity. The negative control plasmid was the vector, pcDNA3.
Stable transfection experiments
In order to stably transfect clones expressing wild and mutant HBx polypep-
tides, cells were plated into six-well plates at a density of 1   105 cells per well
and transferred into serum-free medium for 24 h before transfection experi-
ments. We used 1 lg of the pcDNA3.0 vector to carry the full length and two
mutant HBx plasmids according to the manufacturer’s instructions. Empty
vectors were used as negative controls. Standard calcium phosphate DNA
coprecipitation was used to obtain stable transfectants. To transfect the
pcDNA3.0 vectors into cells, the LipofectamineTM 2000 Mammalian Trans-
fection Kit was used following the manufacturer’s protocol (Invitrogen Life
Technologies). At 24 h after transfection, the medium was replaced with 10%
fetal bovine serum (Gibco-BRL, Grand Island, NY, USA) and 200 lg/ml G418
containing 1% penicillin–streptomycin (Invitrogen Life Technologies), and the
cells were grown for an additional 2 weeks.
Detection of stable transfection
To identify the stably transfected clones expressing wild and mutant HBx
polypeptides, the Neo gene was ampliﬁed from the genomic DNA of the trans-
fected cells by PCR. The DNA from the transfected cells was extracted from
106 cells using the standard phenol–chloroform extraction and ethanol pre-
cipitation method. The following primers were used for ampliﬁcation: forward
primer 5#-ACAAGATGGATTGCACGCAGG-3# and reverse primer 5#-TTC-
TCGGCAGGAGCAAGGTGAG-3#, resulting in a 327 bp expected product.
PCR was performed using a Thermal Cycler 9600 (PerkinElmer, Foster City,
CA) under the following conditions: after denaturation at 94C for 5 min, DNA
ampliﬁcation was performedfor 38 cycles at 94C for45 s, at 56C for 45 s and
at 72C for 60 s, with a ﬁnal extension at 72C for 10 min and then was kept at
4C. The PCR products were analyzed by electrophoresis on a 1% agarose gel
stained with ethidium bromide and sequenced as described previously (22). At
least two independent DNA extractions and PCRs were performed for each
sample, and four sequencing reactions (two for each strand) were carried out
to conﬁrm sequencing data for each sample. The plasmid pHBXB1, containing
the full-length HBx gene cloned into the pcDNA3 vector, was used as positive
controls. For western blot analysis, cells cultured in 35 mm culture dishes
were scraped and lysed. Immunoblots were probed with the corresponding
primary antibodies (1:400) and developed by using the EnVision system
(K139211, Dako, Carpinteria, CA) and the western blot detection kit (ECL
Plus, Santa Cruz Biotechnology, Delaware Avenue Santa Cruz, CA) (24).
RNA isolation
Total RNA from the Huh7 cells transfected with full-length HBx or HBx
mutants was isolated using the Trizol reagent, according to the manufacturer’s
instructions (Invitrogen Life Technologies). The concentration of RNA was
quantiﬁed by measuring the ultraviolet absorbence at 260 nm using a Pharma-
cia GeneQuant RNA/DNA calculator. The RNA was further puriﬁed on an
afﬁnity resin column (RNeasy; Qiagen, Chatsworth, CA) and converted to
cDNA using the Superscript cDNA synthesis kit (Gibco-BRL, Gaithersburg,
MD). Double-stranded cDNA was then puriﬁed by a phase lock gel (Eppen-
dorf, Westbury, NY) with phenol–chloroform extraction.
cDNA microarray expression analysis
To determine the relative gene expression proﬁles in Huh7 cells transfected
with HBx mutants, we analyzed the relative abundance of messenger RNA
(mRNA) using high-density oligonucleotide microarrays containing probes
for 21 074 transcripts (including 20 228 known human genes and 846 ESTs,
human oligo array; Agilent, G4110B Agilent technologies Co. Ltd., shanghai,
China) accordingto the protocols described previously (25,26). In brief, 2 lgo f
sample mRNA and 2 lg of reference mRNA were labeled with Cy3-NTP and
Cy5-NTP (PerkinElmer), respectively, using reverse transcriptase (Invitrogen
Life Technologies) for 2 h at 42C. The two labeled cDNA probes were sep-
arated from unincorporated nucleotides by ﬁltration, mixed and hybridized to
themicroarrayat60Covernight.After hybridization,arrayswerescannedwith
an Agilent microarray scanner. The image ﬁles were analyzed with the Agilent
2100Bioanalyzer program (Agilent)toquantitatetherelative amountofmRNA
in the HBx mutant and full-length HBx-transfected Huh7 cells samples. All
non-ﬂagged array elements for which the ﬂuorescent intensity in each channel
was .1.5 times thanthe local background were considered well measured(27).
Genes for which ,75% of measurements across all the samples met this stan-
dard were excluded from further analysis. The Cy3:Cy5 normalized intensity
ratio for each expressed sequence tag was averaged from duplicate spots in
replicate experiments. Genes with expression levels that differed by at least 2-
fold from the mean in at least one sample were selected for further evaluation.
Preparation of protein samples
Soluble protein fractions were extracted from the Huh7 cells transfected with
full-length HBx or HBx mutants. The samples were lyophilized prior to the
extraction, and the extraction was accomplished using the Klose method as
described previously (2829).
Two-dimensional electrophoresis
Twomilligramsofthetotalproteinwasusedforeachelectrophoresisexperiment.
Aliquots of proteins in sample buffer were applied onto immobilized pH 3–10
non-linear gradient strips (immobilized pH gradient strips; Bio-Cyte, Hercules,
CA and Bio-Rad, Hercules, CA). Isoelectrofocusing was performed at 70 000
voltage hours. The second dimension was performed on 10–16% linear gradient
polyacrylamide gels (17 cm   17 cm   1.5 mm) at 30 mA per gel constant
current for  5 h, until the dye front reached the bottom of the gel. After protein
ﬁxation with a solution containing 40% methanol and 5% phosphoric acid for 1
h, the gels were stained with Coomassie blue G250 for 2 h. The gels were then
destained with a solution containing 0.1% ethanol and 10% acetic acid, scanned
in a Bio-Rad G710 densitometer and converted into electronic ﬁles, which were
then analyzed with PDQUEST computer software (Bio-Rad, Hercules, CA).
Protein identiﬁcation
For identiﬁcation, several protein samples per spot of interest were excised
from the gels stained with Coomassie brilliant blue. Peptide mass spectrometry
ﬁngerprinting after tryptic in-gel digestion was used as described previously
(29). Identiﬁcation of proteins was accomplished by searching the National
Center for Biotechnology Information and/or Mascot databases with MS-Fit or
PeptIdent, respectively. A mass deviation of 0.1 Da and two incomplete cleav-
ages were allowed. Identiﬁcations were accepted when they covered at least
30% of the whole sequence and when comparable molecular mass/P values
were obtained from the databases.
Validation of microarray data
To validate the microarray results and to further clarify a difference in the
expression pattern for wingless-type murine-mammary-tumour virus (MMTV)
integration site family, member 5A (Wnt-5a) in HBV-associated HCC, we
carried out semiquantitative reverse transcription–polymerase chain reaction
(RT–PCR), western blotting, immunohistochemistry and HBx sequencing. In-
dependent tissue samples from 41 HCC patients and corresponding non-can-
cerous liver tissues were obtained during surgeries at the Changhai hospital
between August 2003 and October 2004. All patients had HBsAg-positive
serum. Histopathological diagnosis was made according to the World Health
Organization histological classiﬁcation of tumors of the liver and intrahepatic
bile ducts (2000) (30).
RT–PCR and real-time RT–PCR
Total RNAwas isolated, and cDNAwas synthesized from frozen HCC tissues
and corresponding non-cancerous liver tissues, and the RT–PCR and relative
quantitation by real-time RT–PCR was performed using SYBR-green detec-
tion of PCR products in real-time with a Light Cycler (Roche Diagnostics,
Mannheim, Germany) as described previously (31). The primer sequences for
the gene were as follows: Wnt-5a,5 #-ACCACATGCAGTACATCGGAG-3#
and 5#-GAGGTGTTATCCACAGTGCTG-3# (103 bp) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), a housekeeping gene used as an internal
quantitative control: 5#-TCCACCACCCTGTTGCTGTA-3# and 5#-ACCA-
CAGTCCATGCCATCAC-3# (452 bp). The cycling conditions were as fol-
lows: initial denaturation at 95C for 10 min, followed by 40 ampliﬁcation
cycles of 95C for 30s, 60C for 30s and 72C for 1.5 min. For quantiﬁcation,
the relative standard curves were created for each gene product. GAPDH was
used for normalization of the concentration. Relative expression was calcu-
lated as a ratio of the expression in the tumor compared with that in the
corresponding non-cancerous liver tissue.
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Total protein was extracted from frozen tumor tissues and their corresponding
non-cancerous liver tissues as described above. Protein samples were quantiﬁed
by the Bradford assay and denatured at 100C for 5 min in a protein sample
buffer containing 1% sodium dodecyl sulfate and 1% dithiothreitol. Twenty
microgram of total protein extracts were loaded in each lane and subjected to
15% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred
to Bio-Rad membranes. Speciﬁc antisera used to probe the membranes included
mouse anti-Wnt-5a (AF645, 1: 500, R&D Systems Co. Ltd., Shanghai, China)
and rabbit polyclonal anti-b-actin (Santa Cruz Biotechnology) antibodies. Sub-
sequently, membranes were probed with the corresponding secondary antibodies
and developed using the EnVision system (K139211, Dako) and visualized with
enhanced chemiluminescence (Santa Cruz Biotechnology).
Immunohistochemistry
To evaluate and localize Wnt-5a in HCC tissues, immunohistochemical stain-
ing was performed on carcinomas and the corresponding non-cancerous liver
tissue sections by using anti-Wnt-5a (1:50) with the EnVision Plus System
(Dako). Negativecontrols were included by omitting the primary antibody, and
a known positive control was included with each batch.
PCR and sequence analysis of HBx
To demonstrate the status of HBx mutations and their correlation with Wnt-5a
expression in HCC tissues, genomic DNAwas extracted from frozen HCC tis-
sues and corresponding non-cancerous livertissues, using the standardphenol–
chloroform extraction and ethanol precipitation method. HBx-Alu PCR and
sequencing were performed as described previously (22). At least two inde-
pendent DNA extractions and PCRs were performed for each sample, and four
sequencing reactions (two for each strand) were carried out to conﬁrm the
results for each sample. The plasmid pHBXB1, containing the full-length
HBx gene cloned into the pcDNA3 vector, was used as positive control.
Statistical analysis
All data and statistical analyses were carried out by using a commercially
available statistical software package (SPSS 11.0; SPSS, Chicago, IL). The
differences between Wnt-5a expression in tumor and the corresponding non-
tumorous liver tissues were statistically analyzed by the paired Student’s t-test
for single comparisons and one-way analysis of variance for multiple compar-
isons. The relationship between Wnt-5a protein expression and clinicopatho-
logicalfeaturesofHCCs wasstatisticallyanalyzed byusingthe Pearsonv2 test.
Spearman’sbivariate correlationwasusedtodeterminewhether thereisa positive
or negative correlation between the HBx mutation, Wnt-5a RNA and protein
expression levels. P , 0.05 was considered statistically signiﬁcant.
Results
Detection of HBx deletion mutant plasmid
To investigate the effects on the gene expressions of different HBx
mutants, the PCR products were cloned into a mammalian expression
vector, we constructed four C-terminal mutants of hepatoma cells
with truncated mutants of the HBx gene. The fragment size matched
the predicted fragment by restriction digest (Figure 1a), suggesting
that the correct plasmid construct was present. This was further con-
ﬁrmed by sequencing (Figure 1b), and the Neo gene was ampliﬁed
(Figure 1c). The levels of HBx expression, as measured by western
blotting, were similar for full-length HBx and the two truncated HBx
(HBx3#-30 and HBx3#-40) expression vectors. The puriﬁed different
bands had a molecular size of  17 kDa, corresponding with the size
of the HBx protein (Figure 1d). The results of the biological activities
of hepatoma cells with truncated mutants of the HBx gene showed that
HBx3#-40 at C-terminal mutant promoted cellular proliferation, the
focus formation and elevated tumorigenicity and invasive growth and
metastasis by promote the cell cycle progression from G0/G1 to
S phase; in contrast, HBx3#-30 at C-terminal mutant repressed cell
proliferation by block in G1 phase, when compared with full-length
HBx group (date not shown).
Fig. 1. Detection of HBx deletion mutant plasmid. (A) The fragment size was matched the predicted fragment by restriction digest, suggesting that the correct
plasmid construct was present. (B) The sequencing results have been conﬁrmed theirs success constructed. (C) The Neo gene ampliﬁed by PCR. (D) The full-
length HBx and the four truncated HBx expressionvectors was expressed the hepatitis B X protein antigen by western blot, the puriﬁed bands had a molecular size
of  17 kDa, corresponding with the size of the HBx protein.
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We further analyzed the effects of HBx mutants on the expression
pattern of the transfected Huh7 cells using a cDNA microarray assay
(as shown in supplementary material 2 available at Carcinogenesis
Online). All differentially expressed genes are listed in supplementary
material 3 (available at Carcinogenesis Online). The obvious differ-
entially expressed (.5-fold increase) genes altered by HBx3#-30 and
HBx3#-40 are partially summarized in Table I.
In HBx3#-30-transfected Huh7 cells, 193 of 20 228 genes (0.95%)
showed altered expression compared with the same cells transfected
with full-length HBx. Of the 154 elevated transcripts, 140 were in-
creased 2- to 5-fold, 13 were increased 5- to 10-fold and the expres-
sion of Wnt-5a genewas elevated .10-fold. Of the 39 genes repressed
by HBx3#-30, 38 were decreased 2- to 5-fold and 1 was decreased .5-
fold. In HBx3#-40-transfected Huh7 cells, 165 of 20 228 genes
(0.82%) showed altered expression compared with the same cells
transfected with HBx. All differentially expressed genes are listed
in supplementary material 3 (available at Carcinogenesis Online).
Of the 143 elevated transcripts, 127 were increased 2- to 5-fold, 15
were increased 5- to 10-fold and the expression of 2 genes (carboxy-
peptidase D and one similar to a hypothetical protein) was elevated
.10-fold. Of the 21 genes repressed by HBx3#-40, 18 were decreased
2- to 4-fold and 3 were decreased .4-fold. Of these differentially
expressed genes, most are involved in transcriptional regulation, cy-
toskeletal structure and/or adhesion, signal transduction, metabolism,
apoptosis or the immune response (Figure 2).
Effects of HBx and its mutants on proteomic expression patterns of the
transfected Huh7 cells
The silver-stained 2-D gels of the proteomes expressed in Huh7 cells
transfected with HBx3#-30, HBx3#-40 and full-length HBx are pre-
sented in Figure 3. We detected 741 protein spots in gels of total
protein prepared from the HBx3#-30-transfected Huh7 cells. Of these,
147 were found to have signiﬁcantly different values in the HBx3#-30-
transfected Huh7 cells compared with the cells transfected with full-
length HBx. We were able to detect 549 protein spots in gels of total
protein prepared from the HBx3#-40-transfected Huh7 cells. Of these,
135 were found to have signiﬁcant differences in their expression
compared with the cells transfected with full-length HBx. Of the
differentially expressed proteins, most are involved in pathways
associated with metabolism, transcriptional regulation, cell junctions
and protein degradation. Selected differentially expressed proteins are
listed in supplementary material 4 (available at Carcinogenesis On-
line). Differentially expressed proteins in hepatoma cells expressing
HBx3#-30 or HBx3#-40 determined by mass chromatographic analysis
are shown in supplementary material 4 (available at Carcinogenesis
Online).
In addition, the differentially expressed genes and proteins were
analyzed in HBx mutant-transfected Huh7 cells and compared with
cells transfected with full-length HBx. The results were in agreement
with the cDNA microarray and 2D gel data (data not shown). However,
the expression of a few genes, such as spectrin and ubiquitin-activating
enzyme E1, demonstrated differences in results at the mRNA and pro-
tein levels in the HBx mutant-transfected Huh7 cells.
Wnt-5a expression in HBx mutant-transfected Huh7 cells and in HCC
tissues
To validate our microarray results and to further demonstrate the
difference in the expression pattern for Wnt-5a in cells with mutant
and full-length HBx, we carried out semiquantitative RT–PCR, west-
ern blotting and immunohistochemistry analyses with HCC tissues
and Huh7 cells. The Wnt-5a mRNA and protein expression levels
in Huh7 cells transfected with the HBx3#-30 or HBx3#-40 mutant
and in human clinical HCC and corresponding non-cancerous liver
tissue samples are shown in Figure 4. The levels of these transcripts in
Huh7 cells transfected with the HBx3#-30 or HBx3#-40 mutant, and
the cancer tissues and their corresponding non-tumorous liver tissues
by RT–PCR are shown in Figure 4A. The relative expression levels
of Wnt-5a to GAPDH genes in HBx3#-30 and full-length HBx-
transfected Huh7 cells by using real-time RT–PCR were 25.8 ± 0.47
and 3.15 ± 0.59, respectively. There are statistically signiﬁcant differ-
ences between of them (P , 0.01). In contrast, the expression was
downregulated in HBx3#-40 when compared with full-length HBx-
transfected Huh7 cells (0.45 ± 0.52 versus 3.15 ± 0.59, P , 0.05).
Among the 41 HCC tissue samples, Wnt-5a mRNA was overex-
pressed in 16 samples (39%) and showed decreased expression in 11
samples (26.8%) compared with their corresponding non-cancerous
liver tissues. The relative expression levels of Wnt-5a to GAPDH gene
in HCC and the corresponding non-cancerous liver tissues are shown
in Figure 4B. The relative expression levels of Wnt-5a to GAPDH
gene in HCC compared with the corresponding non-cancerous liver
tissues by using real-time RT–PCR were 7.13 ± 1.28 and 6.08 ± 1.33,
respectively (P 5 0.608). The relative expression levels of Wnt-5a to
GAPDH gene in moderately differentiated and poorly differentiated
cells were 7.74 ± 1.56 and 6.69 ± 1.47, respectively (P 5 0.066).
However, there was no signiﬁcant difference between Wnt-5a
Table I. Positive and negative transcriptional regulation by HBx mutants in hepatoma cells (.5-fold increase)
Genes title Genebank ID Abbreviation Cytoband Ratio (Cy3:Cy5) Description
HBx3#-30 HBx3#-40
Wingless-type MMTV integration site family,
member 5A
L20861.1 Wnt-5a 3p21-p14 14.94301 0.565567 Signal transduction
Chaperone, ABC1 activity of bc1 complex
like (Schizosaccharomyces Pombe)
BC005171.1 CABC1 1q42.13 9.977776 6.510925 Metabolism
1-acylglycerol-3-phosphate O-acyltransferase 3 Q9BTD5 AGPAT3 21q22.3 9.188781 0.944973 Unknown function
Atonal homolog 1 (Drosophila) NM_005172.1 ATOH1 4q22 6.838085 8.93694 Transcriptional regulation
Transcribed sequence with strong similarity
to protein prf:810024G (Homo sapiens)
810024G URF 2
NM_173709.1 MTND2 21 5.528639 6.818047 Metabolism
Histone 1, H2bn BC011372.1 HISTIH2BN 6p22-p21.3 1.119792 9.715353 Chromosome structure
Similar to hypothetical protein AL834319.1 LOC221091 11q12.3 1 10.87552 Cytoskeletal structure
and adhesion
Carboxypeptidase D NM_001304.3 17p11.1-q11.2 1 10.61998 Transcriptional regulation
DnaJ (Hsp40) homolog, subfamily A, member 3 NM_005147.1 Hsp40 16p13.3 0.92649 4.567822 Apoptosis
Netrin-G1 ligand AB046800.1 NGC-1 11p12 0.856526 4.541515 Unknown function
Ets variant gene 5 (Ets-related molecule) BC007333.1 ETV5 3q28 0.853321 4.376849 Oncogene
Phosphatidylinositol transfer protein,
cytoplasmic 1
AAF06148.1 PITPN1 17q24.3 0.849904 9.248197 Signal transduction
Fructosamine-3-kinase-related protein BC007611.1 FN3KRP 17q25.3 0.652204 5.909704 Metabolism
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alpha-fetoprotein concentration, cirrhosis, tumor capsule and intra-
hepatic metastasis.
The expression pattern of the Wnt-5a gene was further investigated
at the protein level, as measured semiquantitatively by immunoblot-
ting. As shown in Figure 4C and D The expression of the Wnt-5a
protein was upregulated in HBx3#-30-transfected Huh7 cells com-
pared with the cells transfected with full-length HBx (4.23 ± 0.77
versus 0.35 ± 0.21, P , 0.01). In contrast, the expression was not
signiﬁcantly different in HBx3#-40-transfected Huh7 cells compared
with the cells expressing full-length HBx (0.30 ± 0.25 versus 0.35 ±
0.21, P . 0.01). Wnt-5a protein was generally present in signiﬁcantly
lower levels in the tumor tissues than in the corresponding non-
cancerous liver tissues. The relative expression levels of Wnt-5a to
b-actin in HCC compared with the corresponding non-cancerous liver
tissues by using western blot were 2.34 ± 0.87 and 0.87 ± 0.48,
respectively (P , 0.01).
To determine whether there is a positive or negative correlation
between the mRNA and protein expression levels, Spearman’s bivar-
iate correlation analysis was performed; however, no statistical cor-
relation was found between the mRNA and protein expression levels
in HCC and corresponding non-cancerous liver tissues.
Strongly positive Wnt-5a immunoreactivity was observed in 29 of
41 (70.7%) non-cancerous liver tissues. In hepatocytes, the Wnt-5a
protein was strongly and uniformly stained in both the cytoplasm and
nucleus; all of the surrounding connective tissues, including blood
vessels and bile ducts, were negative. The HCC cells were stained
in various patterns, being categorized as diffusely to focally positive
in 12 patients (29.3%) and negative in 29 patients (70.7%) (supple-
mentary material 5 is available at Carcinogenesis Online).
The correlation between HBx mutations and Wnt-5a expression in
HCC tissues
To demonstrate the status of HBx mutations and their correlation with
Wnt-5a expression in HCC tissues, HBx-Alu PCR and sequencing
were performed for each sample. The results showed that deletions
in HBx gene were signiﬁcantly higher in HCC than that of non-
cancerous livertissues (33/41 versus 10/41, P , 0.001). Among them,
the deletion of HBx C-terminal was detected in 28 HCC tissues.
Spearman’s chi-square analysis results showed that there was
Fig. 2. Bar graphs showing the proﬁle of the differentially expressed genes
in cells transfected with the HBx3#-30 and HBx3#-40 mutants. The
differentially expressed genes are involved in transcriptional regulation,
cytoskeletal integrity and adhesion, signal transduction, metabolism,
apoptosis and the immune response.
Fig. 3. Two-dimensional gel electrophoresis of protein expression in Huh7 cells transfected with the HBx3#-30 or HBx3#-40 mutant, or with full-length HBx. The
red arrow indicates overexpressed protein, and green arrow indicates decreased protein expression.
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1211a negative correlation between the expression of Wnt-5a immunore-
activity and the HBx COOH mutations in HCC tissues (r 5  0.368,
P 5 0.018). However, no obviously correlation between the upex-
pression of Wnt-5a mRNA and the HBx COOH mutations in HCC
tissues was found (Table II).
Discussion
Although epidemiological and experimental data support a link be-
tween HBV infection and HCC, the underlying mechanisms are not
fully understood. Several efforts have been devoted to exploring the
role of the HBx protein in liver carcinogenesis (3). We have previ-
ously analyzed the structure of the HBx in malignant and normal non-
cancerous liver tissues obtained from HCC patients who were serum
HBsAg positive, demonstrating a high rate of HBx mutation in both
tumor and non-tumor tissues (22). The deletion of amino acids at the
C-terminal end is a major feature identiﬁed in tumor tissues by se-
quence analysis (5,21,32). Tu et al. (32) reported that the C-terminal
region of HBx is crucial to its transcriptional function and that, in
tumor tissues, most HBx natural mutants have lost their capacity for
controlling cell proliferation, viability and transformation. Our results
further conﬁrmed that a variety of mechanisms are involved in the
functions of the HBx C-terminus and that mutations within this region
may directly affect cell proliferation and invasion by regulating cell
cycle and apoptosis. These results suggest that mutations of HBx exist
in the clonally expanding hepatocytes, supporting the hypothesis that
HBx C-terminal deletions have a critical role in liver carcinogenesis.
In the present study, the hypothesis that different deletions at the
C-terminal end, such as HBx3#-30 and HBx3#-40, may have different
biological consequences in regulating cell proliferation and invasion
was investigated by genomic and proteomic expression proﬁling us-
ing cDNA microarray, two-dimensional electrophoresis and mass
spectrometry ﬁngerprinting assays. The results demonstrate that the
majority of the differentially expressed genes and proteins are mainly
involved in key cellular functions, such as transcriptional regulation,
oncogenesis, cell junction formation, signal transduction, metabolism
and the immune response.
Unexpectedly, we found that the expression of Wnt-5a differed
signiﬁcantly and in opposite directions after cells were transfected
with two different HBx mutants. Wnt-5a was upregulated by the
HBx3#-30 mutant, but downregulated by the HBx3#-40 mutant. These
changes, to the best of our knowledge, have not been described pre-
viously and may explain the different patterns of Wnt-5a expression
observed in human HCC tissues. The importance of Wnt-signaling
pathway in liver diseases has been indicated by several reports
(17,33–35). b-catenin is central in the Wnt/b-catenin-signaling path-
way and can be targeted for proteasome-mediated degradation (36).
The ultimate result of Wnt/b-catenin pathway activation is the forma-
tion of a free, signaling pool of b-catenin in the cell that then enters
the nucleus and forms a complex with members of the Lymphoid
enhancer factor/T cell factor proteins family of transcription factors
to regulate the expression of target genes (36–38). In addition, dys-
function of the Wnt-signaling pathway can cause developmental de-
fects and cancer (39,40). Wnt-5a, a member of the Wnt family, has
been shown to be upregulated in many human cancers (41–44).
Wnt-5a antagonizes the canonical Wnt pathway by promoting the
degradation of b-catenin, possibly suppressing tumor formation.
This pathway is seven in-absentia homolog 2 and anaphase-promoting
complex dependent, but glycogen synthase kinase-3 and b-TrCP in-
dependent (41). Cha et al. (45) found that HBx is involved in
Fig. 4. Wnt-5a mRNA and protein expression in Huh7 cells transfected with the HBx3#-30 or HBx3#-40 mutant, and in human clinical HCC and corresponding
non-cancerous liver tissue samples. (A) RT–PCR. Wnt-5a mRNA was upregulated in HBx3#-30-transfected Huh7 cells but downregulated in HBx3#-40-
transfected Huh7 cells, compared with cells expressing full-length HBx. Wnt-5a mRNA expression varies in human HCCs when compared with their
corresponding non-cancerous liver tissues. (B) Real-time RT–PCR. No statistically signiﬁcant difference in Wnt-5a mRNA expression was found between HCC
and the corresponding non-cancerous liver tissues. (C) Western blotting. The expression of Wnt-5a protein was upregulated in HBx3#-30-transfected Huh7 cells,
but was not signiﬁcantly different in HBx3#-40-transfected Huh7 cells, compared with cells transfected with full-length HBx. (D) The protein was present at
signiﬁcantly lower levels in the tumor tissues than in the corresponding non-cancerous liver tissue (P , 0.01); N, non-tumor; T, HCC; Bars, mean; columns,
standard deviation.
Table II. The correlation between the Wnt-5a expression and the HBx
COOH mutations in HCC tissues
HBx COOH mutation P value
Wnt-5A þ 
Immunoreactivity
þ 5 7 0.018
  23 6
mRNA upexpression
þ 9 7 0.194
  19 6
X.Liu et al.
1212activating Wnt/b-catenin signaling in hepatoma cells. Ectopic expres-
sion of HBx along with Wnt-1 activates the Wnt/b-catenin signaling in
Huh7 cells by stabilizing cytoplasmic b-catenin, which is achieved by
suppressing glycogen synthase kinase 3 activity via activation of Src
kinase. Our results in this study demonstrate that there is abnormal
expression of Wnt-5a mRNA in  65% of HCC tissues. There was
a tendency toward an inverse relationship between Wnt-5a expression
and the tumor histological grades. Low HBx protein expression and
a high rate of HBx mutation, particularly deletions of amino acids at
the C-terminal end, were found in the tumor tissues. However, no
statistically signiﬁcant difference was found between HCC and the
corresponding non-cancerous liver tissues, and no statistical correla-
tion was found between the mRNA and protein expression levels (46).
Thus, the biological consequence and the mechanisms with respect to
the role Wnt-5a in HBV-associated HCC need further investigation.
Our results also indicate that there is a correlation between HBx
gene expression and cell proliferation. In HBx3#-30-transfected Huh7
cells, the expression of genes related to cell growth-suppressive ca-
pacity, such as DHRS4L2, MTA2 and SERPINB5, was upregulated,
and myc, a key regulator of cell proliferation, cell growth, differenti-
ation and apoptosis, was downregulated. The upregulated expression
of oncogene Ets (47,48) (4.376849), LOC221091 (10.87552),
MMP10 (49) and MMP13 (50) was observed in the HBx3#-40-
transfected Huh7 cells. These genes have been linked to cell growth,
angiogenesis, cell junction disruption and extracellular matrix degra-
dation. These results suggest that the 40 aa deletion at the C-terminal
end would promote cell growth and invasion. These changes have not
yet been found in human HCC samples.
In conclusion, differential expression of genes and proteins
has been observed following transfection of Huh7 cells with HBx
C-terminal deletion mutants. Most of the differentially expression
genes and proteins are involved in transcriptional regulation, onco-
genesis, cell junction maintenance, signal transduction, metabolism
and the immune response. Changes in Wnt-5a expression were found
in some of the analyzed HCC tissues. These results support the hy-
pothesis that mutant forms of HBx gene are involved in liver carci-
nogenesis, possibly through Wnt-5a-signaling pathways, providing a
better understanding of the function of HBx in hepatocarcinogenesis.
Supplementary material
Supplementary materials can be found at http://carcin.oxfordjournals.
org/
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